Abbreviated Name

Liver Full Ref Set App:Yamada (2011)

Lead Investigator

Yamada, Hiro — Wako Diagnostics

Coordinating Investigator

Feng, Ziding — Fred Hutchinson Cancer Center

Involved Investigators

• Feng, Ziding — Fred Hutchinson Cancer Center
• Yamada, Hiro — Wako Diagnostics
• Srivastava, Sudhir — National Cancer Institute

Abstact

Aims

The specific aim of the proposal is to determine usefulness of the HCC biomarkers in early detection.

Analytic Method

Sensitivity and specificity of AFP, AFP-L3 and DCP assays on the μTASWako i30 will be calculated for the patients using several cutoff values (5%, 7%, 10% etc). Sensitivity by tumor characteristics (stage, size and number) will be evaluated, if the clinical information on the patient characteristics is available.

Biomarkers

• AFP
• AFP-L3
• DCP

Data Collections

• No data collections available at this time for thie protocol

 Team Project

Protocol ID

334

Protocol Type

Reference Set

Field of Research

Proteomics

Collaborative Group

G.I. and Other Associated Cancers Research Group

Cancer Types

• Liver cell carcinoma

Phased Status

2